Acelrx Pharmaceuticals reported $48.31M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US USD 48.31M 7.82M
Baxter International BAX:US USD 27.97B 3.87B
Becton, Dickinson and BDX:US USD 53.13B 195M
Cara Therapeutics CARA:US USD 213.51M 13.06M
Heron Therapeutics HRTX:US USD 271.95M 27.99M
Intra Cellular Therapies ITCI:US USD 782M 29.91M
Pain Therapeutics PTIE:US USD 207.29M 20.1M
Smiths SMIN:LN GBP 5.22B 657M
Teva Pharmaceutical TEVA:IT USD 44.25B 1.68B
Xeris Pharmaceuticals Inc XERS:US USD 303.02M 15.6M